NH
Therapeutic Areas
Sensible Medical Innovations Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ReDS™ System | Pulmonary congestion monitoring in heart failure and other fluid‑related conditions | Commercial |
Leadership Team at Sensible Medical Innovations
AL
Avi Ludomirski
CEO
AB
Aital Bergman
CFO
JD
John DeChellis
EVP Sales
SB
Shlomi Bergida
VP Product
NM
Nadav Mizrahi
VP R&D
RS
Ronit Shaanan
VP Quality Affairs
EG
Elad Gelbart
VP Clinical Affairs
WA
William Abraham
Advisory – Ohio State University
SA
Stefan Anker
Advisory – Charité University
DB
Dan Bensimhon
Advisory – Cone Health